Articles>> Volume 5 Issue 2, 2021

Isolation of a new flavanone and evaluation of antidiabetic activity from Clematis buchananiana aerial parts
U.P.Bhatt, Sudhir Kumar, Bipin Rawat, Subhash Chandra, Sarla Saklani and R.P.Bahuguna
Curr Med Drug Res 5 (2): Art. ID 216 (2021)
The present study aimed to explore the phytochemistry and antidiabetic activity of Clematis buchananiana DC. A new compound (1) characterized as 3-[(11’’-hydroxy, 3’’,6’’,10’’,10’’- tetramethyldodecene)] 6-[(3’’’,4’’’,4’’’-trimethylhexene)] 5,7,2’,4’,6’pentahydroxy 8, 3’,5’ tri methyl flavanone was isolated from the aerial parts of the plant. The methanolic extract of the plant at a concentration of 1 mg/mL showed a 75.00% reduction in α-amylase and 73.13% in α- glucosidase enzyme activity. Moreover, the methanolic extract at 100 mg/kg b.w. showed a significant decline in blood glucose levels of alloxan-induced diabetic rats both in acute and chronic studies. The results were compared with glibenclamide, an oral hypoglycemic agent, which was used as a positive control. The present study concludes that the plant has substantial antidiabetic potential in diabetic rats. These results are indicative and further studies are needed to revalidate the findings.

Related Article

Self-reported effects of dysmenorrhea and its impact on health-related quality of life among female students of three tertiary institutions in Delta State of Nigeria
Peter A.Owonaro, Benedicta C.Uweru, John E.Arute and Joshua F.Eniojukan
Curr Med Drug Res 5 (2): Art. ID 217 (2021)

Therapeutic potential of medicinal herbs in the management of COVID-19
Rishabh, Sonali Verma, Manni Rohilla, Anjali Garg and Randhir Singh
Curr Med Drug Res 5 (2): Art. ID 218 (2021)

Abstracting and Indexing